umifenovir has been researched along with Catarrh in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bulgakova, VA; Grekova, AI; Leneva, IA; Lvov, NI; Maleev, VV; Poromov, AA; Pshenichnaya, NY; Selkova, EP; Shestakova, IV | 1 |
Deeva, EG; Kiselev, OI; Kulikova, EV; Leneva, IA; Maleev, VV; Nadorov, SA; Obukhov, AA; Osipova, EA; Selkova, EP | 1 |
2 trial(s) available for umifenovir and Catarrh
Article | Year |
---|---|
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR).
Topics: Adolescent; Adult; Aged; Antiviral Agents; Common Cold; Double-Blind Method; Female; Humans; Indoles; Influenza, Human; Male; Middle Aged; Respiratory Tract Infections; Russia; Severity of Illness Index; Treatment Outcome; Young Adult | 2019 |
[Clinical efficacy of arbidol (umifenovir) in the therapy of influenza in adults: preliminary results of the multicenter double-blind randomized placebo-controlled study ARBITR].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Common Cold; Double-Blind Method; Female; Humans; Indoles; Influenza, Human; Male; Middle Aged; RNA, Viral; Russia; Severity of Illness Index; Treatment Outcome; Young Adult | 2015 |